Vasopressin Use During Dilation and Curettage
For dilation and curettage procedures, inject 20 mL of highly diluted vasopressin solution (0.05 U/mL, prepared as 4 units in 80 mL normal saline) into the cervical stroma at the 4- and 8-o'clock positions, just beneath the mucosal surface, immediately before cervical dilation.
Preparation and Dosage
The optimal vasopressin preparation for D&C involves significant dilution to minimize systemic effects while maximizing local hemostatic benefit 1, 2:
- Concentration: 0.05 U/mL (4 units of vasopressin in 80 mL normal saline total)
- Volume: 20 mL total injected intracervically
- Timing: Administer immediately before cervical dilation begins
This concentration is substantially more dilute than standard vasopressin preparations and differs from the FDA-labeled intramuscular dosing (5-10 units) used for other indications 3.
Injection Technique
Intracervical injection is the evidence-based route for D&C procedures 1, 2:
- Inject into the cervical stroma at 4- and 8-o'clock positions
- Place injections just beneath the mucosal surface of the cervix
- Distribute the 20 mL volume between these two sites
- Perform injection immediately before beginning cervical dilation
The intracervical route specifically reduces the force needed for mechanical cervical dilation by 45% (mean force 20.29 lb vs 37.05 lb with placebo) 1.
Clinical Benefits During D&C
Intracervical vasopressin provides multiple measurable benefits during uterine procedures 2, 4:
- Reduces intraoperative blood loss by approximately 39% (mean 20.3 mL vs 33.4 mL with placebo) 2
- Decreases distention fluid intravasation by 45% (448.5 mL vs 819.1 mL) 2
- Shortens operative time by approximately 9% (31.1 minutes vs 34.1 minutes) 2
- Facilitates cervical dilation with significantly less force required, particularly beneficial in nulliparous patients 1
For operative hysteroscopy specifically, vasopressin reduces the risk of fluid intravasation to 0.36 times that of placebo 4.
Alternative Technique for Hemorrhage Control
In cases of refractory postabortion or postpartum hemorrhage where standard D&C has failed, paracervical vasopressin injection combined with operative hysteroscopy represents an alternative approach 5:
- This technique may avoid major surgical interventions
- Inject vasopressin paracervically (rather than intracervically)
- Perform under direct hysteroscopic visualization
- Consider when preparing for surgical intervention but seeking to avoid it
Important Caveats and Contraindications
Critical safety considerations when using vasopressin during gynecologic procedures 6, 7:
- Vasopressin causes systemic vasoconstriction and can increase blood pressure
- Avoid in patients with cardiovascular disease, particularly those with coronary artery disease or hypertension
- Monitor for bradycardia, which may require atropine 600 mcg IV 7
- Watch for vasovagal episodes, though intracervical administration may reduce this risk compared to other routes 8
- Excessive doses cause blanching, abdominal cramps, and nausea—give 1-2 glasses of water at time of administration to reduce symptoms 3
Do not confuse this highly diluted local technique with the much higher concentrations used for laparoscopic procedures in ectopic pregnancy management (0.02 U/mL, prepared as 20 units in 1000 mL) 9.
Context: D&C in Modern Practice
While D&C was historically the primary diagnostic method for endometrial evaluation, it has largely been replaced by less invasive techniques (Pipelle sampling, hysteroscopy) for diagnostic purposes 10, 11, 10. However, D&C remains relevant for:
- Therapeutic management of abnormal bleeding 12
- Postabortion or postpartum hemorrhage 5
- Situations requiring tissue evacuation
When D&C is performed, vasopressin significantly improves the safety profile and procedural ease 1, 2.